Lv1
48 积分 2021-10-11 加入
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
1个月前
已完结
Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood
1个月前
已完结
Engineering CAR T cells to secrete VEGF-neutralizing scFvs enhances antitumor activity against solid tumors
1个月前
已完结
The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity
3个月前
已完结
Current advances in colorectal cancer treatment: a review of recent clinical trials
3个月前
已完结
A new first-line standard-of-care for BRAFV600E-mutated mCRC
3个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
3个月前
已完结
Current advances in colorectal cancer treatment: a review of recent clinical trials
3个月前
已完结
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
5个月前
已完结
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
5个月前
已完结
皖公网安备34019202002308
